Építés alatt – nem éles oldal
Belépés
Résztvevőt keres itt: OlaszországFázis nélkül

Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in Multiple Sclerosis

A legfontosabb adatok

Hol
Cagliari (Olaszország)A helyszín megnézése

AI-kivonat: kiket keres a vizsgálat

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

A vizsgálat olyan felnőtteket keres, akiknek igazolt sclerosis multiplex (SM) betegségük és enyhe mozgáskorlátozottságuk van, valamint egészséges kontrollszemélyeket, két járás- és lábmozgás-teszt vizsgálatához.

Életkor
18 és 65 év között.
Nem
Férfiak és nők is részt vehetnek.
A betegség stádiuma
Igazolt SM, EDSS-pontszám 0 és 3,5 között, legalább 30 napja nem volt SM-roham.

A részvétel fő kizáró okai

  • Az SM-en kívül más idegrendszeri betegség
  • Olyan gondolkodási vagy emlékezeti zavar, amely miatt a tesztek és kérdőívek nem végezhetők el
  • Más idegrendszeri, csont- és ízületi vagy látási probléma, amely a járást befolyásolja

Gépi kiolvasás: 2026. november 12.

Neked szólhat?

Magadról válaszolj. Ez nem döntés: hogy részt vehetsz-e, azt csak a vizsgálat csapata mondhatja meg.

  • 18 és 65 év között vagy?

Forrás: NCT07505355: ki vehet részt

Helyszínek itt: Olaszország

  • Laboratorio di Biomeccanica ed Ergonomia industriale Università degli Studi di CagliariCagliari, OlaszországContact: Massimiliano PauRésztvevőt keres

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

A vizsgálat adatai

Ki végzi
Hasselt University
Azonosító
NCT07505355
A regiszteradat frissítve
2026. április 1.
Eredeti leírás
Walking and motor control impairments are among the most common manifestations experienced by people with multiple sclerosis (pwMS) and may already be present in individuals with mild disability. Subtle changes in walking performance can reflect early disease progression, highlighting the need for sensitive clinical outcome measures that capture complex, real-world mobility. Commonly used assessments primarily quantify time or distance and may lack sensitivity to detect early or subtle functional changes in daily-life walking. Successful everyday mobility requires gait adaptability, defined as the ability to continuously adjust walking patterns in response to environmental or task-related challenges, including the processing of external perturbations and internal factors such as fatigue, balance confidence, and fear of falling. Despite its clinical relevance, gait adaptability is not specifically addressed by currently validated clinical tests in pwMS. The Walking Adaptability Ladder Test (WALT), which challenges the interaction between step length, cadence, and walking speed through continuous adjustments, and the Foot Tap Test (FTT), which assesses lower limb motor control and rhythmic coordination, have demonstrated promising measurement properties in other populations but have not yet been evaluated in pwMS. The primary aim of this study is to examine the test-retest reliability and construct validity of the WALT and FTT in pwMS with mild disability. Secondary aims include evaluating the measurement properties of the Balance Recovery Scale and the Gait-Specific Attention Scale in pwMS with mild disability, identifying inertial measurement unit-derived metrics that best discriminate pwMS with low disability from healthy controls, and exploring whether relationships between clinical motor test outcomes and self-reported measures provide complementary insights into subtle gait impairments.A teljes eredeti leírásKevesebb

Measurement Properties of the Walking Adaptability Ladder Test and Foot Tap Test in People With Multiple Sclerosis With Mild Disability

Walking and motor control impairments are among the most common manifestations experienced by people with multiple sclerosis (pwMS) and may already be present in individuals with mild disability. Subtle changes in walking performance can reflect early disease progression, highlighting the need for sensitive clinical outcome measures that capture complex, real-world mobility. Commonly used assessments primarily quantify time or distance and may lack sensitivity to detect early or subtle functional changes in daily-life walking. Successful everyday mobility requires gait adaptability, defined as the ability to continuously adjust walking patterns in response to environmental or task-related challenges, including the processing of external perturbations and internal factors such as fatigue, balance confidence, and fear of falling. Despite its clinical relevance, gait adaptability is not specifically addressed by currently validated clinical tests in pwMS. The Walking Adaptability Ladder Test (WALT), which challenges the interaction between step length, cadence, and walking speed through continuous adjustments, and the Foot Tap Test (FTT), which assesses lower limb motor control and rhythmic coordination, have demonstrated promising measurement properties in other populations but have not yet been evaluated in pwMS. The primary aim of this study is to examine the test-retest reliability and construct validity of the WALT and FTT in pwMS with mild disability. Secondary aims include evaluating the measurement properties of the Balance Recovery Scale and the Gait-Specific Attention Scale in pwMS with mild disability, identifying inertial measurement unit-derived metrics that best discriminate pwMS with low disability from healthy controls, and exploring whether relationships between clinical motor test outcomes and self-reported measures provide complementary insights into subtle gait impairments.

Bevonási feltételek: confirmed diagnosis of definite MS,; relapse free at least 30 days,; Expanded Disability Status Scale (EDSS) score between 0 and 3.5.

Kizáró feltételek: diagnosed with neurological disease other than MS; cognitive decline that renders the patient incapable of performing tests and questionnaires; other neurological, orthopedic, or visual impairments affecting gait.

ClinicalTrials.gov NCT07505355